CVKD
Cadrenal Therapeutics, Inc. Common Stock
NASDAQ: CVKD · HEALTHCARE · BIOTECHNOLOGY
$6.67
+19.32% today
Updated 2026-04-30
Market cap
$13.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.64
Dividend yield
—
52W range
$4 – $17
Volume
0.1M
Cadrenal Therapeutics, Inc. Common Stock (CVKD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | $778174.00 | $8.52M | $10.12M |
| Cash & equivalents | $32586.00 | $8.40M | $10.02M |
| Current assets | $727596.00 | $8.49M | $10.11M |
| Total liabilities | $6.33M | $826875.00 | $2.68M |
| Current liabilities | $1.33M | $826875.00 | $2.68M |
| Long-term debt | $553340.00 | — | — |
| Shareholder equity | $-5.55M | $7.69M | $7.44M |
| Retained earnings | $-6.71M | $-15.07M | $-25.72M |
| Accounts receivable | — | — | $38153.00 |
| Inventory | — | — | — |
| Goodwill | — | — | — |